ABAlison Bethel

Alison Bethel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alison Bethel has a total of 96 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Extra care housing in the UK: a scoping review

    by Sian de Bell, Zhivko Zhelev, Alison Bethel, Jo Thompson Coon, Rob Anderson

    Background: Extra care housing is a model of housing for older people where residents live in self-contained accommodation with flexible care and support available at all times. Ageing populations, seen globally and in the United Kingdom, mean increasing demand for this type of housing. While extra care housing may help people live longer independently, its provision poses challenges (e.g. resourcing flexible care). By identifying existing evidence, this scoping review will inform future research into extra care housing, to support the development of schemes that meet the needs of older people. Objectives: To identify the volume, focus/questions, study design, quality and main findings of empirical research and evaluations relating to extra care housing in the United Kingdom. Methods: We conducted a scoping review of evidence syntheses and primary research. Applied Social Sciences Index and Abstracts, Cumulated Index in Nursing and Allied Health Literature, MEDLINE, Health Management Information Consortium, ProQuest Dissertations and Theses Global, Social Policy and Practice (SPP) and Web of Science, along with relevant websites, were searched for studies (June 2024). We also completed citation-chasing on included studies. We included systematic reviews and empirical evaluations published since 2010, conducted in the United Kingdom, focused on extra care housing for older people, and investigating any outcome. Data were tabulated and summarised narratively. Critical appraisal was conducted using the Mixed Methods Appraisal Tool checklist (primary studies) or A MeaSurement Tool to Assess systematic Reviews 2 (systematic reviews). Consultation with stakeholders and extra care housing residents informed the review. Results: Ninety-eight publications were included. Thirty-seven were qualitative, 28 were quantitative, 19 took a mixed-method approach and 2 were modelling studies using secondary data. Older people were participants in 57 studies. Many studies provided limited information on the characteristics of participants and the included extra care housing schemes. Included studies had three overlapping areas of focus: (1) the supply of extra care housing and older people’s decision-making regarding relocation; (2) living in extra care housing (e.g. impact on quality of life, residents’ experiences of community, physical infrastructure); and (3) leaving extra care housing (there was little research in this area). While much of the available research supports the provision of extra care housing as a model of housing with care for older people, studies were variable in their methodological quality and reporting. Consultation with extra care housing residents raised topics that corresponded with the findings of included studies (e.g. the importance of care provision in supporting independence). Limitations: Extra care housing is known by different names (e.g. assisted living). This created challenges in finding studies and understanding whether the housing model being studied met our definition of extra care housing. As we took an inclusive approach, some included studies may have focused on other types of housing with care. Conclusions: There is a growing body of evidence regarding the provision of extra care housing as a model of housing for older people. However, given the changing health and social care landscape and increasing care needs of the population, further research is needed to support the future development of extra care housing. Future work: High-quality research on effectiveness and cost-effectiveness is needed, as well as on specific topics (e.g. whether extra care housing can be a home for life). Study registration: The protocol was published on Zenodo (https://doi.org/10.5281/zenodo.12698241). Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: NIHR174287) and is published in full in Health and Social Care Delivery Research ; Vol. 14, No. 26. See the NIHR Funding and Awards website for further award information.

  • Open Access

    Effects of antibiotics on the abundance of antibiotic resistance determinants during and after antibiotic administration to beef cattle: A systematic review and meta-analysis of longitudinal studies

    by Matt Lloyd Jones, Alfredo Sánchez-Tójar, Alison Bethel, Anne Frances Clare Leonard, Emma Lamb, Natalia Andrea Casanova, Johana Dominguez, María Paula Quiroga, Daniela Centron, Adriana Peralta Alonso, et al.

    Background: Beef feedlots are increasing concerns that antibiotic use in beef cattle selects for antibiotic resistance, but limitations of primary studies and previous syntheses make it difficult to confirm a consistent effect. We conducted a rigorous systematic review and meta-analysis to summarise: 1) the effect during and after antibiotic administration; 2) its moderation by time since administration started/ended. Methods: Eligible studies longitudinally compared beef cattle administered antibiotics to those that were not, measuring resistance determinants in faeces and/or environments. Information sources included Web of Science, CAB Abstracts, and Medline (last searches: 05/03/25). Risk of bias was assessed using RoB 2 and ROBINS-I. Meta-analysis was conducted where feasible, using individual participant data where necessary. Results: The 33 included studies were mostly small trials of North American feedlot cattle, all with high risks of bias. Meta-analysis of 11 studies of tylosin, ceftiofur, and chlortetracycline indicated positive effects on absolute abundance of resistance both during (SMDH = 0.4; 95% CI = 0.11 to 0.69, p = <0.01) and after (SMDH = 0.52; 95% CI = 0.33 to 0.71, p = <0.01) antibiotic administration. Log-transformed time was positively associated with effect size during (Slope = 0.63; 95% CI = 0.1 to 1.16, p = 0.02), and negatively associated after (Slope = -0.65; 95% CI = -1.24 to -0.06, p = 0.03) Discussion: Available evidence indicates time-dependent selection for antibiotic resistance in beef cattle, warranting further regulation to limit human health risks. Simultaneously, uncertainty about precise effect sizes warrants further research. Funding: BBSRC Registration: https://doi.org/10.17605/OSF.IO/RXQHT

  • Open Access

    The Effectiveness of Contact Tracing to Reduce Transmission of Infectious Diseases During Epidemic or Pandemic Response: Rapid Systematic Review

    by Michael Nunns, Samantha Febrey, Kieran Becker, Morgan Weiland, Jill Buckland, Rebecca Abbott, Rebecca Whear, Alison Bethel, Liz Shaw, Kate Boddy, et al.

    Background: Contact tracing (CT), the process of identifying and managing contacts of infected cases, is one public health and social measure that may reduce the spread of infectious diseases. While previous systematic reviews of CT exist, a comprehensive review of both the effectiveness and potential unintended consequences has not been undertaken to our knowledge. Understanding effective CT strategies could help governments and health authorities prepare effectively for emergency epidemic or pandemic situations. Objective: This study aims to systematically review the evidence on the effectiveness of CT across infectious diseases with epidemic or pandemic potential. Effectiveness is measured in terms of impacts on disease transmission, health care use, mortality, or unintended consequences. Methods: We searched 6 bibliographic databases (MEDLINE, Embase, Global Health, CINAHL Ultimate, Cochrane, and Scopus) between November 29 and December 3, 2024, with supplementary citation searching. We sought human studies comparing CT with interventions with no CT or other forms of CT, delivered in the community, in prespecified diseases of epidemic or pandemic potential. We included studies with any measure of disease transmission, related health care use, or unintended consequences of CT and prioritized studies with concurrent comparators. Screening, data extraction, and critical appraisal were performed in duplicate. Due to substantial heterogeneity, a narrative synthesis was performed. This review was informed by meetings with a patient and public involvement and engagement group. Results: After deduplication, a total of 12,816 titles and abstracts were screened, with 198 records assessed for eligibility at full text. Five additional studies were found through supplementary searching. Finally, 88 reports (of 86 studies) were included, of which 57 reports (of 55 studies) were prioritized. Two main routes of transmission were represented: respiratory (tuberculosis [TB], 15 studies; COVID-19, 5 studies) and blood-borne or sexually transmitted infections (STIs; 35 studies, of which 13 were in HIV, and 22 were bacterial or parasitic infections). No evidence was found on vector-borne, direct contact, or food- or water-borne routes of transmission. Evidence was highly heterogeneous, and more than half of the studies had notable methodological limitations. While there was no difference between CT and comparator interventions for most outcomes, there was some evidence of reductions in disease prevalence in TB and for provider-initiated CT to be superior to patient-led approaches in STIs. Only 2 studies reported measures of unintended consequences. Conclusions: We found inconsistent evidence for the effectiveness of CT, focused primarily on TB and on contrasts between provider-initiated CT and patient-led referral in STIs and HIV. High heterogeneity in study design precluded clear assertions regarding optimal strategies for CT, including with respect to relevant subgroups. Future work should consider generalizability of CT mechanisms across contexts, including by route of transmission and from the Global South, and a more thorough account of unintended consequences.


  • Open Access

    Effectiveness and cost-effectiveness of targeted and population screening for osteoporosis in women: scoping review

    by Kieran Becker, Morgan Weiland, Samantha Febrey, Michael Nunns, Jill Buckland, Rebecca Abbott, Rebecca Whear, Alison Bethel, Elizabeth Shaw, Kate Boddy, et al.

    Background: Osteoporosis is a systemic skeletal disorder characterised by bone tissue deterioration, leading to reduced bone density and increased susceptibility to fractures. Osteoporosis screening is the process of identifying people with an increased risk of osteoporosis by using risk assessment tools or medical imaging. The National Institute for Health and Care Excellence recommends opportunistic risk assessment in women over 65 years or under 65 years with risk factors, though this guideline was last updated in 2017. Regular surveillance of the available evidence is warranted to gauge the volume and type of evidence published on key issues relating to population-based and targeted screening for osteoporosis. Objectives: To identify and review the volume and type of evidence on effectiveness and cost-effectiveness of population-based and targeted osteoporosis screening in women and to explore the consideration of health equity in the evidence base. Design and methods: Two information specialists developed the search strategy in MEDLINE (via Ovid) and translated it to 10 other databases. The title and abstract then full text of each record were screened by two independent reviewers. Disagreements were resolved through discussion. Records found through supplementary searches were single-screened as were reference lists of relevant guidelines identified. One reviewer completed data extraction of included studies, with a second reviewer checking the accuracy. Setting and participants: Included studies were required to be experimental designs, systematic reviews or cost-effectiveness studies with a standard care comparator. Populations of interest were women over 65 years and women below 65 years with osteoporosis risk factors. Interventions: Any population or targeted screening intervention involving any combination of risk assessment and dual energy X-ray absorptiometry scan designed to identify women with, or at risk for, osteoporosis. Main outcome measures: Outcomes related to osteoporosis prevention (osteoporotic fractures, all-cause fractures and mortality), possible screening harms and cost-effectiveness. Data sources: Searches were conducted in 11 databases and were supplemented by forward and backward citation searching. Review methods: Study characteristics and equity considerations were tabulated and narratively described. Results: The 19 included studies consisted of 3 randomised controlled trials with 9 sibling papers, 1 non-concurrent cohort study and 6 reviews. The primary studies generally included women 65 years old and older, with interventions involving several risk assessment and screening methods. Most reviews investigated the general population and included either bone mineral density measurement or clinical risk assessment for screening. Studies mainly reported fracture outcomes, with some quality-of-life and cost-effectiveness measures. Equity-relevant features analysed by studies included education, relationships, income and age. Limitations: Our inclusion criteria may have excluded some evidence discussed by other related reviews. Conclusions: Evidence on the effectiveness and cost-effectiveness of osteoporosis screening is limited, with reviews mainly drawing conclusions from the same few primary studies currently available. The evidence base lacks consideration of equity-related characteristics. Future work: High-quality trial evidence is required, particularly for targeted screening. Equity characteristics should be addressed in future work. Anticipated impact and dissemination: The review aims to identify gaps in the current evidence base for targeted and population osteoporosis screening to inform future research and healthcare policy-makers’ decisions. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Evidence Synthesis programme as award number NIHR169162.

  • Top Cited Papers
    Open Access

    Physical activity interventions for older adults – an overview of systematic reviews

    by Jo Canneaux, Richard A. Sharpe, Noreen Orr, Jane R. Smith, Alison Bethel, Cassandra Phoenix, Victoria A. Goodwin, Iain Lang, Ruth Garside

    Background: The proportion of people meeting recommended physical activity (PA) guidelines declines with age. Older adults who are physically inactive have an increased risk of: all-cause mortality; chronic diseases; injury and reduced cognitive functioning. Multiple systematic reviews aim to understand the effectiveness of PA interventions but the evidence is fragmented and it is unclear how well the research reflects the needs of older people. We conducted an overview of existing systematic reviews (PROSPERO reference: CRD42015023796) to map evidence on interventions to encourage older people to be more active. Methods: Nine electronic databases were searched, most recently in October 2023. Older people were defined as those aged 50+, with physical activity including active daily living (walking the dog, gardening, etc.), organised activities and clubs and more formal exercise or sport. Screening of records, data extraction, and assessments of quality (using AMSTAR-2) and inequality (using Progress-Plus) were completed independently by two reviewers. Results: A total of 35 reviews (reported in 36 papers) published between 2002 and 2023 were included. Reviews included between 3 and 79 studies (total 480 unique studies) with a median of 162 and 184 participants per study in meta-analyses (overall AMSTAR-2 median quality low) and narrative syntheses (median quality critically low) respectively. Eighteen included a mixture of interventions (e.g. supporting lifestyle change, walking groups, exercise classes), nine focussed on remote delivery, six on wearable devices, five on 1-to-1 interventions, two on walking, and two focussed on group-based interventions. Interventions to increase physical activity in older people were shown to be effective in the short term (< 12 months). The use of wearable devices as interventions had a small-to-medium effect on increasing physical activity and daily steps. Remote delivery approaches, including the use of text messaging, web- or mobile-technology, and social media, were effective in increasing PA. Conclusions: A range of interventions are effective in increasing PA in older adults. Newer research highlights the usefulness of technology - including wearable devices, social media, text messaging - as useful tools. Improved effectiveness seems to relate to theory-based interventions, but without further research, caution should be taken when interpreting the effectiveness of individual behaviour change techniques. Identifying and resolving wider barriers and facilitators, social and environmental interactions influencing PA may improve future interventions. Better reporting of equity by future studies will improve understanding of who benefits from such interventions. Increased knowledge of potential wider social, economic and environmental determinants of physical activity in older adults, and specifically more vulnerable and minority populations, will help policy makers and practitioners develop more effective interventions.


  • Open Access

    Extra Care Housing in the United Kingdom: A Systematic Scoping Review

    by Zhivko Zhelev, Siân de Bell, Alison Bethel, Rob Anderson, Jo Thompson Coon

    Extra care housing (ECH) is a model of housing for older people where residents live in self‐contained accommodation with flexible care and support available 24/7. Whilst ECH may help people live independently for longer, its provision also poses challenges. This scoping review aimed to summarise empirical research relating to ECH in the United Kingdom to inform commissioning of further research. Primary research on ECH published after 2010 was included. ASSIA, CINAHL, Medline and four further databases were searched in June 2024, along with relevant websites and citation‐chasing. Two reviewers independently selected studies for inclusion. One reviewer conducted and a second reviewer verified data extraction. Data were tabulated and summarised narratively. Critical appraisal was conducted using the mixed‐methods appraisal tool. Ninety‐eight publications were included in the review. Qualitative studies had fewer methodological limitations than quantitative and mixed‐methods studies. Many studies provided limited information on the characteristics of participants and the included ECH schemes. Studies reported effectiveness, costs, resident or staff experiences or other aspects (e.g., accessibility) of living in ECH. Most studies focused on moving into or living in ECH, with few examining whether and how older people leave ECH. There is a growing body of evidence supporting the provision of ECH as a model of housing for older people. However, given the changing health and social care landscape and increasing care needs of the population, further research is needed to support the future development of ECH. Specific research gaps include guidance on choosing the most appropriate housing option, best practice for supporting people with high care needs and helping them transition from ECH to another care setting, coordination between housing and care providers, managing diverse and evolving communities and including older people from social minority groups. Future studies should follow best practice guidelines and reporting standards.

  • Open Access

    Does Creative Bibliotherapy delivered in schools improve mental health-related outcomes for 5–16 year olds? A systematic review

    by Hayley Redman, Daniel Mutanda, Alison Bethel, Rachel Miller, G. J. Melendez-Torres, Judith Green

    There is an increasing need for effective interventions for child and adolescent mental health promotion, with mixed evidence to date on what works. Creative Bibliotherapy has promise as a pragmatic, school-based approach. We undertook a systematic review of experimental or quasi-experimental studies of Creative Bibliotherapy designed to be delivered by teachers in schools to improve any mental health related outcome for children aged 5-16. Of 3405 unique reports retrieved, 23 met the inclusion criteria. The majority were student research dissertations (n = 12); conducted in North America (n = 17); conducted in children aged 12 or under (n = 17). Of the 13 (57%) which reported positive impact on mental health outcomes, authors described the selection of diverse and appropriate materials; structured interaction; and trained delivery by school-based practitioners as important to success. These were neither necessary nor sufficient conditions. Few studies were well defended against risk of bias. There are promising indications that Creative Bibliotherapy in schools can improve mental health and its contributors but, to date, no strong evidence. Much of the literature pre-dates widespread adoption of reporting guidelines, and few designs were robustly defended against bias. Whilst interventions such as Creative Bibliotherapy fit uneasily within experimental evaluation paradigms, many interventions identified in this review could be evaluated with stronger trial designs to identify both positive and negative effects, and (more importantly) the contexts and conditions under which they are likely to improve children's mental health.


  • Open Access

    Effectiveness, cost effectiveness and experiences of switching from intravenous to oral antibiotics in neonates with probable early onset sepsis: a systematic review

    by Rebecca Whear, Rebecca Abbott, Harriet Aughey, Morwenna Rogers, Alison Bethel, Stuart Logan, Kelly Boxall, Jo Thompson Coon

    Objective: To assess the effectiveness, cost-effectiveness and experiences of switching from intravenous antibiotics to oral antibiotics in neonates with suspected early onset sepsis (EOS). Design: Systematic review. Patients: Clinically stable term and later preterm neonates with suspected EOS. Interventions: Oral antibiotics. Main outcome measures: Mortality and morbidity, cost and resource use, family related and process outcomes and experiences of families and health care professionals. Information sources: We searched Medline, Embase, PsycINFO, HMIC, SPP, CENTRAL, CINAHL and Conference Abstracts (via Web of Science) in April 2025. Database searches were supplemented with citation chasing, contacting authors and website searches. Methods: Screening, data extraction and critical appraisal was performed in duplicate. Due to heterogeneity of outcomes, timepoints and lack of reported data relating to the data distribution, a narrative synthesis was performed. The review was informed by public collaborators interested in maternal health. Results: After de-duplication, 3803 titles and abstracts were screened for relevance with 27 assessed for eligibility at full text. Following title and abstract screening, one randomised controlled trial (504 neonates) and three observational studies (795 neonates) were included. Length of stay was reduced by between 1 to 4 days across all four studies. No differences were observed between study arms in those reporting on readmission rates, reinfection or mortality. Conclusions: This systematic review suggests that switching clinically stable term and late pre-term neonates with suspected EOS from intravenous to oral antibiotics can reduce hospital stay and healthcare costs without increasing morbidity, mortality, or readmission. Key messages: What is already known on this topic Intravenous antibiotics are commonly prescribed in neonatal care to treat suspected early onset sepsis (EOS). Distinguishing infectious from non-infectious cases is difficult, often leading to unnecessary intravenous antibiotic treatment in uninfected neonates. A recent systematic review of oral antibiotics for neonatal infections concluded that in general, adequate serum levels can be achieved after oral administration of antibiotics in neonates. What this study adds There is promising evidence that switching clinically well, term and late preterm neonates with suspected EOS from intravenous to oral antibiotics reduces duration of hospital stay with no impact on readmissions, clinical deterioration, mortality, or reinfection. How this study might afect research, practice or policy Future research should focus on longer-term outcomes such as effects on the gut microbiome and later childhood health, evaluations of cost-effectiveness, incorporating both healthcare system and family perspectives, and ensure that equity considerations are fully addressed.


  • Open Access

    The Effectiveness of Contact Tracing to Reduce Transmission of Infectious Diseases During Epidemic or Pandemic Response: Rapid Systematic Review (Preprint)

    by Michael Nunns, Samantha Febrey, Kieran Becker, Morgan Weiland, Jill Buckland, Rebecca Abbott, Rebecca Whear, Alison Bethel, Liz Shaw, Kate Boddy, et al.

    BACKGROUND Contact tracing (CT), the process of identifying and managing contacts of infected cases, is one public health and social measure that may reduce the spread of infectious diseases. While previous systematic reviews of CT exist, a comprehensive review of both the effectiveness and potential unintended consequences has not been undertaken to our knowledge. Understanding effective CT strategies could help governments and health authorities prepare effectively for emergency epidemic or pandemic situations. OBJECTIVE This study aims to systematically review the evidence on the effectiveness of CT across infectious diseases with epidemic or pandemic potential. Effectiveness is measured in terms of impacts on disease transmission, health care use, mortality, or unintended consequences. METHODS We searched 6 bibliographic databases (MEDLINE, Embase, Global Health, CINAHL Ultimate, Cochrane, and Scopus) between November 29 and December 3, 2024, with supplementary citation searching. We sought human studies comparing CT with interventions with no CT or other forms of CT, delivered in the community, in prespecified diseases of epidemic or pandemic potential. We included studies with any measure of disease transmission, related health care use, or unintended consequences of CT and prioritized studies with concurrent comparators. Screening, data extraction, and critical appraisal were performed in duplicate. Due to substantial heterogeneity, a narrative synthesis was performed. This review was informed by meetings with a patient and public involvement and engagement group. RESULTS After deduplication, a total of 12,816 titles and abstracts were screened, with 198 records assessed for eligibility at full text. Five additional studies were found through supplementary searching. Finally, 88 reports (of 86 studies) were included, of which 57 reports (of 55 studies) were prioritized. Two main routes of transmission were represented: respiratory (tuberculosis [TB], 15 studies; COVID-19, 5 studies) and blood-borne or sexually transmitted infections (STIs; 35 studies, of which 13 were in HIV, and 22 were bacterial or parasitic infections). No evidence was found on vector-borne, direct contact, or food- or water-borne routes of transmission. Evidence was highly heterogeneous, and more than half of the studies had notable methodological limitations. While there was no difference between CT and comparator interventions for most outcomes, there was some evidence of reductions in disease prevalence in TB and for provider-initiated CT to be superior to patient-led approaches in STIs. Only 2 studies reported measures of unintended consequences. CONCLUSIONS We found inconsistent evidence for the effectiveness of CT, focused primarily on TB and on contrasts between provider-initiated CT and patient-led referral in STIs and HIV. High heterogeneity in study design precluded clear assertions regarding optimal strategies for CT, including with respect to relevant subgroups. Future work should consider generalizability of CT mechanisms across contexts, including by route of transmission and from the Global South, and a more thorough account of unintended consequences. CLINICALTRIAL

  • Open Access

    The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review

    by Michael Nunns, Samantha Febrey, Jill Buckland, Rebecca Abbott, Rebecca Whear, Alison Bethel, Kate Boddy, Liz Shaw, Jo Thompson Coon, Gj Melendez-Torres

    Background: Glucagon-like peptide 1 receptor agonists are a class of drug originally developed to treat type 2 diabetes but now increasingly used for weight loss, especially in people living with obesity. Despite an abundance of evidence about the effectiveness and safety of glucagon-like peptide 1 receptor agonists for weight loss, network meta-analyses are inconsistent in their quality and scope, and this is a fast-moving field. Objectives: We sought to identify the most recent network meta-analyses evaluating the effectiveness of glucagon-like peptide 1 receptor agonists for weight loss; critically appraise included network meta-analyses; provide an overview of the quality and findings of existing network meta-analyses, and identify any pertinent gaps in the evidence; and consider the value of updating the most recent, comprehensive and high-quality network meta-analyses. Methods: On 6 June 2023, we searched MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews and Epistemonikos for systematic reviews with network meta-analyses published since 2020 in adults (18 or above) with body mass index ≥ 25 (or ≥ 23 for Asian populations), including at least one relevant glucagon-like peptide 1 receptor agonist and weight loss outcomes. We screened and selected reviews in duplicate and independently, and appraised reviews using a modified A MeaSurement Tool to Assess systematic Reviews 2 (AMSTAR-2) and a network meta-analysis reliability checklist. The highest-quality reviews were then extracted in depth, and the most relevant network meta-analysis models identified, focusing on weight loss and safety outcomes. A top-up search for trials published since October 2022 was also undertaken to identify relevant trials not included in published network meta-analyses. A further search for new network meta-analyses was conducted on 26 September 2024. Results: Of 22 systematic reviews identified, 14 were prioritised for analysis as the remaining 8 reviews were rated as low or critically low quality. We focused on network meta-analyses of weight loss outcomes measured at 6 months, 12 months, longer than 12 months or over a mix of time points. At 6 months, subcutaneous tirzepatide was the most effective drug associated with 9 kg (at 5 mg) to 12 kg (at 15 mg) of weight loss. However, the largest effects were seen for subcutaneous semaglutide 2.4 mg, which was associated with between 11.5 and 12.5 kg of weight loss, though this came from two network meta-analyses, both informed by six trials, and both merging findings across multiple time points. The relative effectiveness among glucagon-like peptide 1 receptor agonists followed a pattern suggested by their performance against placebo, with tirzepatide and semaglutide standing out as the most effective drugs for weight loss. No network meta-analyses compared tirzepatide and semaglutide 2.4 mg. The drugs associated with the greatest weight loss, tirzepatide and semaglutide 2.4 mg, were generally associated with increased risk of safety issues compared to placebo. The update trial search identified 11 new trials, which, though largely small, could make a new network meta-analysis useful. The update search for network meta-analyses yielded 13 new includes. Among other novel comparisons, tirzepatide was indirectly compared with semaglutide 2.4 mg, outperforming it at 15 mg, but not 5 or 10 mg. Data again came from merged time points. Discussion: To our knowledge, this is the first review of network meta-analyses of glucagon-like peptide 1 receptor agonists. The evidence presented regarding weight loss is in general agreement with the wider literature, though data on tirzepatide were not as resounding as reported in some meta-analyses. Limitations: Current network meta-analyses of glucagon-like peptide 1 receptor agonists with weight loss outcomes often lack clarity about the network meta-analysis methods, such as which trials were included. The tendency to combine multiple doses of drugs, and to merge findings from multiple time points, limits our understanding of dose and time effects. Future work: Head-to-head trials of tirzepatide versus semaglutide 2.4 mg are required to determine their relative effectiveness and safety, as the two most promising options for weight loss, as are longer-term trials to establish the effectiveness and safety of glucagon-like peptide 1 receptor agonists when taken for durations of > 72 weeks. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Evidence Synthesis programme as award number NIHR159924.